BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27658583)

  • 1. Hypoxia promotes chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling pathways.
    Petit C; Gouel F; Dubus I; Heuclin C; Roget K; Vannier JP
    BMC Cancer; 2016 Sep; 16(1):746. PubMed ID: 27658583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment.
    Frolova O; Samudio I; Benito JM; Jacamo R; Kornblau SM; Markovic A; Schober W; Lu H; Qiu YH; Buglio D; McQueen T; Pierce S; Shpall E; Konoplev S; Thomas D; Kantarjian H; Lock R; Andreeff M; Konopleva M
    Cancer Biol Ther; 2012 Aug; 13(10):858-70. PubMed ID: 22785211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells.
    Zou J; Li P; Lu F; Liu N; Dai J; Ye J; Qu X; Sun X; Ma D; Park J; Ji C
    J Hematol Oncol; 2013 Jan; 6():3. PubMed ID: 23289374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
    Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
    Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines.
    Gu L; Zhang G; Zhang Y
    J Exp Clin Cancer Res; 2019 Jun; 38(1):269. PubMed ID: 31221196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yin-Yang-1 decreases Fas-induced apoptosis in acute lymphoblastic leukemia under hypoxic conditions: its implications in immune evasion.
    Martínez-Torres E; López-Pérez TV; Morales-Martínez M; Huerta-Yepez S
    Bol Med Hosp Infant Mex; 2020; 77(4):186-194. PubMed ID: 32713953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104.
    Benito J; Shi Y; Szymanska B; Carol H; Boehm I; Lu H; Konoplev S; Fang W; Zweidler-McKay PA; Campana D; Borthakur G; Bueso-Ramos C; Shpall E; Thomas DA; Jordan CT; Kantarjian H; Wilson WR; Lock R; Andreeff M; Konopleva M
    PLoS One; 2011; 6(8):e23108. PubMed ID: 21853076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells.
    Yang B; Fan L; Fang L; He Q
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):540-6. PubMed ID: 16520989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.
    Cheng ZX; Wang DW; Liu T; Liu WX; Xia WB; Xu J; Zhang YH; Qu YK; Guo LQ; Ding L; Hou J; Zhong ZH
    Oncol Rep; 2014 Apr; 31(4):1891-8. PubMed ID: 24535079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-apoptotic protein BIM in apoptosis of glucocorticoid-sensitive and -resistant acute lymphoblastic leukemia CEM cells.
    Zhao YN; Guo X; Ma ZG; Gu L; Ge J; Li Q
    Med Oncol; 2011 Dec; 28(4):1609-17. PubMed ID: 20697841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption.
    Zhao H; Shi P; Deng M; Jiang Z; Li Y; Kannappan V; Wang W; Li P; Xu B
    Oncotarget; 2016 Dec; 7(51):85515-85528. PubMed ID: 27888802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1.
    Rebucci M; Sermeus A; Leonard E; Delaive E; Dieu M; Fransolet M; Arnould T; Michiels C
    Mol Cancer; 2015 Apr; 14():79. PubMed ID: 25889892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergism of MCL1 and glycolysis on pediatric acute lymphoblastic leukemia cell survival and prednisolone resistance.
    Ariës IM; Hansen BR; Koch T; van den Dungen R; Evans WE; Pieters R; den Boer ML
    Haematologica; 2013 Dec; 98(12):1905-11. PubMed ID: 24142999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytochemical Modulation of Apoptosis and Autophagy: Strategies to Overcome Chemoresistance in Leukemic Stem Cells in the Bone Marrow Microenvironment.
    Owen HC; Appiah S; Hasan N; Ghali L; Elayat G; Bell C
    Int Rev Neurobiol; 2017; 135():249-278. PubMed ID: 28807161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Insulin-mediated Regulation of AKT Signaling in Childhood Acute Lymphoblastic Leukemia.
    Wang J; Xue HM; Chen YR; Xu HG; Lin SF; Tang XK; Chen C
    J Pediatr Hematol Oncol; 2019 Mar; 41(2):96-104. PubMed ID: 30688831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of heme oxygenase-1 in microenvironment mediates vincristine resistance of B-cell acute lymphoblastic leukemia by promoting vascular endothelial growth factor secretion.
    Yu K; Wang J; Lu T; Ma D; Wei D; Guo Y; Cheng B; Wang W; Fang Q
    J Cell Biochem; 2019 Oct; 120(10):17791-17810. PubMed ID: 31264739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib Treatment can Overcome Glucocorticoid Resistance in Childhood B-cell Precursor Acute Lymphoblastic Leukemia Cell Lines.
    Junk S; Cario G; Wittner N; Stanulla M; Scherer R; Schlegelberger B; Schrappe M; von Neuhoff N; Lauten M
    Klin Padiatr; 2015 May; 227(3):123-30. PubMed ID: 25985447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis deregulation influences chemoresistance to azaguanine in human leukemic cell lines.
    Sarmento-Ribeiro AB; Dourado M; Paiva A; Freitas A; Silva T; Regateiro F; Oliveira CR
    Cancer Invest; 2012 Jun; 30(5):331-42. PubMed ID: 22348536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of the cell survival/anti-apoptotic NF-kappaB pathway by the novel humanized BM-ca anti-CD20 mAb: implication in chemosensitization.
    Vega MI; Martínez-Paniagua M; Huerta-Yepez S; González-Bonilla C; Uematsu N; Bonavida B
    Int J Oncol; 2009 Dec; 35(6):1289-96. PubMed ID: 19885551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line.
    Xing H; Yang X; Liu T; Lin J; Chen X; Gong Y
    Leuk Res; 2012 Apr; 36(4):509-13. PubMed ID: 22285507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.